Friday, June 2, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Antimicrobial Resistance

Superbugs & Superdrugs Comes to the U.S.

by Global Biodefense Staff
July 7, 2016
Superbugs & Superdrugs USA

SMi Group’s respected antimicrobial event will travel to the United States this fall for the first Superbugs & Superdrugs USA on 14th and 15th November 2016.

The program will look to address key issues surrounding funding opportunities and U.S. national plans, multi resistance gram negative infections, novel protein based biologics, antimicrobial drug development and more.

Confirmed speakers to date include:

  • Christopher Houchens, Branch Chief, Antibacterial’s Program, BARDA
  • Rosemarie Aurigemma, Chief, Biodefense Drug Development Section, NIH
  • Anthony Simon Lynch, Senior Scientific Director, Janssen Research & Development LLC
  • Alita Miller, Director of Biology, Entasis Therapeutics
  • William J Weiss, Director, Pre-Clinical Services, UNT Health Science Center
  • Domingo Gargallo-Viola, Co-Founder and CSO, ABAC Therapeutics
  • David Cook, Chief Scientific Officer, Blueberry Therapeutics Ltd

This decision to enter the U.S. market follows the show’s 18 years and sell-out success in Europe with an audience a quarter of the audience traveling from the States.

For those who are interested, there is currently a $400 early bird discount available online which expires on July 15th. Further information is available at www.superbugs-usa.com.

Global Biodefense is an official media partner of Superbugs & Superdrugs USA 2016.

Tags: AntimicrobialsASPRBARDAEventsHHSMRSA

Related Posts

Vials of finished vaccines
Funding News

UK Biomanufacturing Fund to Bolster Supply Chain Resilience and Pandemic Preparedness

May 26, 2023
Dr. Sen Pei Discusses Challenges in Forecasting Antimicrobial Resistance
Antimicrobial Resistance

Dr. Sen Pei Discusses Challenges in Forecasting Antimicrobial Resistance

April 26, 2023
Aptitude Awarded Up to $54M BARDA Funding for At-Home Diagnostics
Industry News

Aptitude Awarded Up to $54M BARDA Funding for At-Home Diagnostics

April 20, 2023
Medical Countermeasures

Scientists Design Molecule to Slow SARS-Cov-2 Infection

March 29, 2023
Load More

Latest News

Vials of finished vaccines

UK Biomanufacturing Fund to Bolster Supply Chain Resilience and Pandemic Preparedness

May 26, 2023
Dr. Sen Pei Discusses Challenges in Forecasting Antimicrobial Resistance

Dr. Sen Pei Discusses Challenges in Forecasting Antimicrobial Resistance

April 26, 2023
Biodefense Headlines – 25 April 2023

Biodefense Headlines – 25 April 2023

April 25, 2023
Aptitude Awarded Up to $54M BARDA Funding for At-Home Diagnostics

Aptitude Awarded Up to $54M BARDA Funding for At-Home Diagnostics

April 20, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2023 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2023 Stemar Media Group LLC